https://www.globenewswire.com/news-release/2026/04/14/3273635/0/en/VariZIG-Market-Research-Report-2026-Epidemiology-Pipeline-Analysis-Insights-Forecasts-2020-2035.html
VariZIG Market Research Report 2026: Epidemiology, Pipeline
Opportunities in the varizig market stem from rising VZV infections and healthcare spending, emphasizing passive immunization and high-risk patient...
market research reportepidemiologypipeline
https://www.fda.gov/vaccines-blood-biologics/approved-blood-products/varizig
VARIZIG | FDA
Product approval information is indicated for postexposure prophylaxis in high risk individuals. High risk groups include: o Immunocompromised children and...
fda
https://www.cdc.gov/mmWr/preview/mmwrhtml/mm6112a4.htm?s_cid=mm6112a4_w
FDA Approval of an Extended Period for Administering VariZIG for Postexposure Prophylaxis of...
fda approvalextended